Efficacy of long-term repeated rituximab treatment in refractory phospholipase A2 receptor-antibody-related membranous nephropathy

Immunotherapy, Ahead of Print.

Source: Immunotherapy - September 13, 2022 Category: Allergy & Immunology Authors: Lihua Zhang Mengxing Chen Weibo Le Mingchao Zhang Yuanmao Tu Ke Zuo Dacheng Chen Yan Wu Shijun Li Caihong Zeng Zhen Cheng Honglang Xie Source Type: research